TR200200278T2 - Kalsilitik bileşimler - Google Patents

Kalsilitik bileşimler

Info

Publication number
TR200200278T2
TR200200278T2 TR2002/00278T TR200200278T TR200200278T2 TR 200200278 T2 TR200200278 T2 TR 200200278T2 TR 2002/00278 T TR2002/00278 T TR 2002/00278T TR 200200278 T TR200200278 T TR 200200278T TR 200200278 T2 TR200200278 T2 TR 200200278T2
Authority
TR
Turkey
Prior art keywords
calcilitic
compositions
disorders
treatment
new methods
Prior art date
Application number
TR2002/00278T
Other languages
English (en)
Inventor
Gowen Maxine
J. Suva Larry
Fox John
B. Stroup George
F.Nemeth Edward
Original Assignee
Smithkline Beecham Corporation
Nps Pharmaceuticals, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corporation, Nps Pharmaceuticals, Inc. filed Critical Smithkline Beecham Corporation
Publication of TR200200278T2 publication Critical patent/TR200200278T2/tr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/18—Drugs for disorders of the endocrine system of the parathyroid hormones

Abstract

Kemik hastaliklari veya bozukluklarinin tedavisinde yeni yöntemler saglanmistir.
TR2002/00278T 1999-07-31 2000-07-31 Kalsilitik bileşimler TR200200278T2 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US14677899P 1999-07-31 1999-07-31

Publications (1)

Publication Number Publication Date
TR200200278T2 true TR200200278T2 (tr) 2002-06-21

Family

ID=22518969

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2002/00278T TR200200278T2 (tr) 1999-07-31 2000-07-31 Kalsilitik bileşimler

Country Status (21)

Country Link
EP (1) EP1200076A4 (tr)
JP (1) JP2003505502A (tr)
KR (1) KR20020016928A (tr)
CN (1) CN1367687A (tr)
AU (1) AU764716B2 (tr)
BR (1) BR0012921A (tr)
CA (1) CA2380081A1 (tr)
CO (1) CO5180628A1 (tr)
CZ (1) CZ2002360A3 (tr)
EC (1) ECSP003590A (tr)
HK (1) HK1046238A1 (tr)
HU (1) HUP0202167A3 (tr)
IL (1) IL147875A0 (tr)
MX (1) MXPA02001204A (tr)
NO (1) NO20020466L (tr)
PE (1) PE20010459A1 (tr)
PL (1) PL353318A1 (tr)
TR (1) TR200200278T2 (tr)
UY (1) UY26265A1 (tr)
WO (1) WO2001008673A1 (tr)
ZA (1) ZA200200784B (tr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR030684A1 (es) * 2000-01-24 2003-09-03 Smithkline Beecham Corp Compuestos calciliticos, uso de dichos compuestos en la manufactura de medicamentos, e intermediarios utiles en la preparacion de dichos compuestos
US20030018203A1 (en) 2002-07-17 2003-01-23 Largo Maria Amparo Calcilytic compounds
US6756480B2 (en) 2000-04-27 2004-06-29 Amgen Inc. Modulators of receptors for parathyroid hormone and parathyroid hormone-related protein
MY143244A (en) 2002-11-26 2011-04-15 Smithkline Beecham Corp Calcilytic compounds
US7205322B2 (en) 2003-02-12 2007-04-17 Bristol-Myers Squibb Company Thiazolidine compounds as calcium sensing receptor modulators
US7265145B2 (en) 2003-05-28 2007-09-04 Bristol-Myers Squibb Company Substituted piperidines and pyrrolidines as calcium sensing receptor modulators and method
TW200845956A (en) 2006-12-18 2008-12-01 Smithkline Beecham Corp Calcilytic compounds
WO2013098588A1 (en) * 2011-12-27 2013-07-04 Ubaldo Armato Use of calcilytic drugs as a pharmacological approach to the treatment and prevention of alzheimer's disease, alzheimer's disease-related disorders, and down's syndrome neuropathies
GB201217330D0 (en) 2012-09-28 2012-11-14 Univ Cardiff Therapeutic for treating inflammatory lung disorders
CN108420814A (zh) * 2017-02-15 2018-08-21 四川大学 一种nps-2143用于抗菌的新用途

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG99290A1 (en) * 1996-04-09 2003-10-27 Nps Pharma Inc Calcilytic compounds
PE20000415A1 (es) * 1998-04-08 2000-05-21 Smithkline Beecham Corp Compuestos calciliticos
AR014975A1 (es) * 1998-04-08 2001-04-11 Nps Pharma Inc Compuestos calciliticos, una composicion farmaceutica que los comprende, y el uso de los mismos para la fabricacion de un medicamento

Also Published As

Publication number Publication date
EP1200076A1 (en) 2002-05-02
NO20020466D0 (no) 2002-01-29
HUP0202167A2 (en) 2002-10-28
UY26265A1 (es) 2001-03-16
JP2003505502A (ja) 2003-02-12
HK1046238A1 (zh) 2003-01-03
BR0012921A (pt) 2002-06-18
CO5180628A1 (es) 2002-07-30
CN1367687A (zh) 2002-09-04
CZ2002360A3 (cs) 2002-10-16
KR20020016928A (ko) 2002-03-06
CA2380081A1 (en) 2001-02-08
PL353318A1 (en) 2003-11-17
EP1200076A4 (en) 2005-02-09
NO20020466L (no) 2002-03-20
MXPA02001204A (es) 2004-05-21
HUP0202167A3 (en) 2006-07-28
AU6504100A (en) 2001-02-19
ECSP003590A (es) 2002-02-25
PE20010459A1 (es) 2001-06-11
ZA200200784B (en) 2003-01-29
WO2001008673A1 (en) 2001-02-08
AU764716B2 (en) 2003-08-28
IL147875A0 (en) 2002-08-14

Similar Documents

Publication Publication Date Title
DE60023043T2 (de) (S,S)-Reboxetin zur Behandlung von Inkontinenz
MY155218A (en) Small molecules useful in the treatment of inflammatory disease
HK1024629A1 (en) Monoesters of probucol for the treatment of cardiovascular and inflammatory disease.
DE60023128D1 (de) Pyrazolecarboxamide zur behandlung von fettleibigkeit und anderen erkrankungen
NO20034056D0 (no) Proliferative sykdommer
TR199901172T2 (tr) Yeni ikame edilmis pirazol türevleri.
ATE417602T1 (de) Mittel zur behandlung von erkrankungen der speiseröhre
DE60032795D1 (de) Nordihydroguaiaretinsäurederivate zur behandlung von tumoren
DE60123238D1 (de) Zusammensetzungen zur behandlung von autoimmunkrankheiten
DE10082139T1 (de) Zusammensetzung zur Behandlung von Reibungspaaren
ATE451123T1 (de) Vaginal verabreichbare zusammensetzung zur behandlung von uteriner dysrhythmie
DE60021381D1 (de) Chinonverbindungen zur behandlung von krankheiten
TW200640944A (en) VGF polypeptides and methods of treating VGF-related disorders
MXPA03003741A (es) Metodos y composiciones para el tratamiento de enfermedades oftalmicas.
TR200200278T2 (tr) Kalsilitik bileşimler
ATE271861T1 (de) Verwendung von nmda-antagonisten und/oder natriumkanalantagonisten zur behandlung von entzündlichen erkrankungen
MXPA02000680A (es) Polipeptidos vgf y metodos para tratar desordenes relacionados con vgf.
DE60016047D1 (de) Dihydrobenzopyrane, dihydrobenzothiopyrane und tetrahydrochinoline zur behandlung cox-2-abhängiger krankheiten
ATE230741T1 (de) 3-tetrahydropyridin-4-yl-indole zur behandlung von psychotischen störungen
DE69924284D1 (de) Verwendung von stimulatoren der neurotrophischen faktoren zur behandlung von neurodegenerativen ophthalmischen krankheiten
NO20005548D0 (no) Mykobakterieinhibitorer
ATE343387T1 (de) S-methyl-dihydro-ziprasidon zur behandlung von augenerkrankungen.
ATE226440T1 (de) Zusammensetzung zur behandlung von psoriasis
TR200003084T2 (tr) Paroxetine askorbat
DE60326348D1 (de) Makrozyclen zur behandlung von krebserkrankungen